Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma
PHASE1
This study is designed to evaluate the efficacy and safety of sintilimab-be...
A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma
PHASE2
The study will be a single-center, single-arm, Phase II study of gemcitabin...
A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma
PHASE2
This is a single-arm, multicenter, exploratory clinical study evaluating th...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University